This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Williams, J. P.
Right arrow Articles by Classon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, J. P.
Right arrow Articles by Classon, M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2006, p. 1170-1182, Vol. 26, No. 4
0270-7306/06/$08.00+0     doi:10.1128/MCB.26.4.1170-1182.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

The Retinoblastoma Protein Is Required for Ras-Induced Oncogenic Transformation{dagger}

Jonathan P. Williams,1 Timothy Stewart,1 Bihua Li,1 Roseann Mulloy,1 Dessislava Dimova,2 and Marie Classon1*

MGH Cancer Center and Harvard Medical School, Charlestown, Massachusetts 02129,1 Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey 088542

Received 4 April 2005/ Returned for modification 23 May 2005/ Accepted 20 October 2005

Most human cancers involve either mutational activation of the Ras oncogenic pathway and/or inactivation of the retinoblastoma tumor suppressor (RB) pathway. Paradoxically, tumors that harbor Ras mutations almost invariably retain expression of a wild-type pRB protein. We explain this phenomenon by demonstrating that Ras-induced oncogenic transformation surprisingly depends on functional pRB protein. Cells lacking pRB are less susceptible to the oncogenic actions of H-RasV12 than wild-type cells and activated Ras has an inhibitory effect on the proliferation of pRB-deficient human tumor cells. In addition, depletion of pRB from Ras-transformed murine cells or human tumor cells that harbor Ras pathway mutations inhibits their proliferation and anchorage-independent growth. In sharp contrast to pRB–/– 3T3 cells, fibroblasts deficient in other pRB family members (p107 and p130) are more susceptible to Ras-mediated transformation than wild-type 3T3 cells. Moreover, loss of pRB in tumor cells harboring a Ras mutation results in increased expression of p107, and overexpression of p107 but not pRB strongly inhibits proliferation of these tumor cells. Together, these findings suggest that pRB and p107 have distinct roles in Ras-mediated transformation and suggest a novel tumor-suppressive role for p107 in the context of activated Ras.


* Corresponding author. Mailing address: MGH Cancer Center and Harvard Medical School, Bldg. 149, 13th St., Charlestown, MA 02129. Phone: (617) 726-7804. Fax: (617) 726-7808. E-mail: classon{at}helix.mgh.harvard.edu.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.


Molecular and Cellular Biology, February 2006, p. 1170-1182, Vol. 26, No. 4
0022-538X/06/$08.00+0     doi:10.1128/MCB.26.4.1170-1182.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Nair, J. S., Ho, A. L., Tse, A. N., Coward, J., Cheema, H., Ambrosini, G., Keen, N., Schwartz, G. K. (2009). Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780. Mol. Biol. Cell 20: 2218-2228 [Abstract] [Full Text]  
  • Vormer, T. L., Foijer, F., Wielders, C. L. C., te Riele, H. (2008). Anchorage-Independent Growth of Pocket Protein-Deficient Murine Fibroblasts Requires Bypass of G2 Arrest and Can Be Accomplished by Expression of TBX2. Mol. Cell. Biol. 28: 7263-7273 [Abstract] [Full Text]  
  • Zagorski, W. A., Knudsen, E. S., Reed, M. F. (2007). Retinoblastoma Deficiency Increases Chemosensitivity in Lung Cancer. Cancer Res. 67: 8264-8273 [Abstract] [Full Text]  
  • Knudsen, E. S., Knudsen, K. E. (2006). Retinoblastoma tumor suppressor: where cancer meets the cell cycle.. Exp. Biol. Med. 231: 1271-1281 [Abstract] [Full Text]  
  • Agromayor, M., Wloga, E., Naglieri, B., Abrashkin, J., Verma, K., Yamasaki, L. (2006). Visualizing Dynamic E2F-Mediated Repression In Vivo. Mol. Cell. Biol. 26: 4448-4461 [Abstract] [Full Text]